Position in LQDA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,959,259
+$3,009,086 QoQ
Shares Held
74,743
-4.4% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#75
of 333 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 51%
Shared 0%
None 49%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ESSEX INVESTMENT MANAGEMENT CO LLC holds $27,866,340 across 5 Drug Manufacturers - Specialty & Generic names. LQDA ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
241,382 | $15,436,378 | |
| 2 | LQDA |
Liquidia Corp
This page
|
74,743 | $5,959,259 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
715,608 | $5,667,615 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
|
20,131 | $728,742 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
4,295 | $74,346 |
All Filings in LQDA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,959,259 | 74,743 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,950,173 | 78,171 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||